Skip to content

Safe anesthetic management of the airway during endoscopic procedures using a novel laryngeal mask airway (Gastro LMA)

Use of Gastroâ?¢ Laryngeal Mask Airway® during intravenous sedation for Endoscopic Retrograde Cholangiopancreatography (ERCP) â?? a randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050678
Enrollment
80
Registered
2023-03-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K805- Calculus of bile duct without cholangitis or cholecystitis

Interventions

Control Intervention1: Gastro� Laryngeal Mask Airway®: The Gastro� LMA® is a novel device with the ability to facilitate direct endoscopic access via the integrated endoscopic channel, as well a

Sponsors

JSSAHER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients, 18-65 years of age undergoing ERCP with ASA physical status I, II or II

Exclusion criteria

Exclusion criteria: i) Patients with propofol / egg allergy. ii) Patients with any history or predictors of difficult airway. iii) Patients with increased aspiration risk. iv) Emergency cases (like cholangitis, acute bleeding). v) Patients with abnormal head/neck morphology thus preventing the placement of LMA Gastro device. vi) Patients with head and neck surgery or radiation therapy, making the placement of LMA Gastro device difficult. vii) Pregnant women. viii) Patient refusal for the study procedure.

Design outcomes

Primary

MeasureTime frame
To record the number of intra-procedural cardiorespiratory events, namely hypoxia, hypercapnia, arrhythmias, hypotension.Timepoint: From start of intravenous sedation till completion of ERCP procedure and patient has been assessed to be stable.

Secondary

MeasureTime frame
i) To record the number of attempts required to introduce LMA® Gastro�, and the attempts required to pass endoscope through LMA Gastro. ii) To observe for post-procedure complications, immediate post-procedure sore throat. iii) To record the amount of propofol required to maintain adequate sedation during the procedure. iv) To assess gastroenterologist satisfaction with the LMA® Gastro� device.Timepoint: From time of placement of the Gastro LMA till 2hrs post procedure.

Countries

India

Contacts

Public ContactDr Archana KN

JSSAHER

archanamrnm@yahoo.co.in9845140637

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026